Mesoblast Ltd ADR (NASDAQ:MESO)’s traded shares stood at 0.52 million during the last session, with the company’s beta value hitting 3.50. At the close of trading, the stock’s price was $17.53, to imply a decrease of -4.16% or -$0.76 in intraday trading. The MESO share’s 52-week high remains $19.15, putting it -9.24% down since that peak but still an impressive 90.82% since price per share fell to its 52-week low of $1.61. The company has a valuation of $2.01B, with an average of 1.02 million shares in intraday trading volume over the past 10 days and average of 351.10K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Mesoblast Ltd ADR (MESO), translating to a mean rating of 1.67. Of 10 analyst(s) looking at the stock, 2 analyst(s) give MESO a Sell rating. 0 of those analysts rate the stock as Overweight while 2 advise Hold as 6 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
Mesoblast Ltd ADR (NASDAQ:MESO) trade information
After registering a -4.16% downside in the last session, Mesoblast Ltd ADR (MESO) has traded red over the past five days. The 5-day price performance for the stock is 4.59%, and 58.64% over 30 days. With these gigs, the year-to-date price performance is 696.82%. Short interest in Mesoblast Ltd ADR (NASDAQ:MESO) saw shorts transact 1.42 million shares and set a 6.44 days time to cover.
The extremes give us $11 and $12 for target low and target high price respectively. As such, MESO has been trading 31.55% off suggested target high and 37.25% from its likely low.
Mesoblast Ltd ADR (MESO) estimates and forecasts
Looking at statistics comparing Mesoblast Ltd ADR share performance against respective industry, we note that the company has outperformed competitors. Mesoblast Ltd ADR (MESO) shares are 157.42% up over the last 6 months, with its year-to-date growth rate higher than industry average at 16.85% against 16.60%. The rating firms project that company’s revenue will grow 212.30% compared to the previous financial year.
Revenue forecast for the current quarter as set by 2 analysts is 1.19M. Meanwhile, for the current quarter, a total of 2 analyst(s) estimate revenue growth to 3.38M.
MESO Dividends
Mesoblast Ltd ADR has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is SUMMIT X, LLC with 0.15 million shares, or about 0.1497% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $1.01 million.
We also have Trust for Professional Managers-ActivePassive International Equity ETF and Advisors Preferred Tr-Quantified Global Fund as the top two Mutual Funds with the largest holdings of the Mesoblast Ltd ADR (MESO) shares. Going by data provided on Aug 31, 2024 , Trust for Professional Managers-ActivePassive International Equity ETF holds roughly 46.53 shares. This is just over 0.04% of the total shares, with a market valuation of $0.82 million. Data from the same date shows that the other fund manager holds a little less at 6.4, or 0.01% of the shares, all valued at about 0.11 million.
